Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccines
New findings in cancer vaccines described by J. Zeng and co-researchers
June 24th, 2009
According to a study from Guangzhou, People's Republic of China, "The present study investigated an immunotherapeutic strategy for rearranged during transfection proto-oncogene (ret)associated carcinomas in a transgenic MT/ret 304/B6 mouse model in which spontaneous tumors develop due to overexpression of the ret gene. A Ret peptide vaccine comprising an extracellular fragment of Ret protein and Th1-polarized immunoregulator CpG oligonucleotide (1826) induced strong and specific cellular and Immoral immune responses in wildtype C57BL/6 mice, showing that the Ret peptide has a strong immunogenic potential as part of an antitumor vaccine." "In MT/ret 304/B6 mice, however,...
Source: Vaccine Weekly (2009-06-24)
|
